Saturday, March 25, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Industry News

FDA Initiative to Speed Medical Device Development

by Global Biodefense Staff
December 31, 2012

The US Food and Drug Administration (FDA) is teaming up with industry and non-profit organizations for a new Medical Device Innovation Consortium (MDIC) to advance tools for evaluating the safety, quality and efficacy of medical technologies. 

The partnership was jointly established by the FDA and Minnesota-based trade association LifeScience Alley, with industry representatives from companies including: Abiomed, BD, Boston Scientific, CVRx, Medtronic, Cyberonics, and Immucor Gamma. 

The MDIC is the first ever public-private partnership created with the sole objective of advancing medical device regulatory science. The intent is to be a national 501c(3) organization that operates in partnership with the FDA that creates a safe haven for pre-competitive collaborative research on medical devices between academia and industry. 

The FDA hopes to utilize the consortium to improve the validation process for devices and to prioritize funding and regulatory science decisions. “For the first time, we can determine priorities, bring together collaborative minds and analyze post-market values to determine safety and efficacy,” stated Jeffrey Shuren, Director of the FDA’s Center for Devices and Radiological Health. 

Unlike other countries that require only proof of safety for medical device approval, FDA standards also require demonstration of efficacy in treating a specific disease or medical condition.  Making the approval process more efficient will lessen the lag time to bring devices to patients in the U.S. 

Read more at the Medical Device Innovation Consortium website.

Tags: Healthcare Cybersecurity

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC